This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hospitals Face Billions Of Dollars In Losses Due To ACA Readmissions Rules

Plantation, FL, Aug. 1, 2013 (GLOBE NEWSWIRE) -- To  help hospitals address the Hospital Readmission Reduction Program (HRRP) provision of the Affordable Healthcare Act, Health Revenue Assurance Holdings, Inc. (OTCBB: HRAA) has developed Readmissions Visualizer TM to improve and protect revenue by predicting which patients are at high risk for readmissions.

Readmissions Visualizer TM, currently being beta tested by multiple hospital systems, is a predictive modeling analytics solution.  The product focuses on readmission improvement metrics on high risk patients so hospitals can improve their readmissions profile. Hospital employees ranging from senior level administrators to care managers can utilize Readmissions Visualizer TM to identify trends in readmissions, flag patients that are at risk of being readmitted and prioritize action-oriented plans to reduce their likelihood of returning.

Under HHRP the Centers of Medicare and Medicaid (CMS) will fine hospitals for high rates of Medicaid patients -- treated for conditions that include heart failure and pneumonia -- who are readmitted within 30 days of being discharged. The program is expected to save CMS billions of dollars over the next seven years and put thousands of hospitals at financial risk if they do not curb rates.

"A typical hospital with 350 beds will lose between $2.5 and $3 million over three years if they have a poor readmissions rate. We know, from years of working with more than 900 hospitals, which key indicators improve predictions that a patient is at high risk of readmission. These risk factors include poor support systems in the home, prescription medication payment concerns, accessibility of health services and other social and economic data," said Michael Gallagher, MD, chief medical officer of HRAA.

Readmissions Visualizer TM provides hospitals with the ability to view current inpatient and historical readmission information through an intuitive Web interface. Key features include:
  • Readmission Dashboard - View of monthly Readmission Results for HF, AMI, Pneumonia, and COPD with patient detail by Practice or Provider.
  • Near -Miss Analysis- View of Emergency Room, Urgent Care and Observation Status to reveal gaps and indicate processes that can be improved.
  • Current Risk - View of  current census including Read for Admission, History of CHF/AMI/PN, Readmission Risk Score, Emergency Room History, and Follow-Up Appointments.

"In order to impact readmissions of Medicare patients, hospitals need a way to monitor their performance," continued Dr. Gallagher. "CMS penalties will hurt, and every dollar a hospital loses threatens their ability to provide quality healthcare services to patients."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs